GoodRx Holdings, Inc.
GDRX
$2.04
-$0.04-1.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.91% | 0.40% | 1.23% | 2.57% | 0.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.91% | 0.40% | 1.23% | 2.57% | 0.99% |
| Cost of Revenue | 43.23% | 14.85% | 12.47% | 7.19% | 14.27% |
| Gross Profit | -4.87% | -0.52% | 0.52% | 2.26% | 0.22% |
| SG&A Expenses | -5.21% | 0.05% | -6.44% | -7.04% | -9.91% |
| Depreciation & Amortization | 21.21% | 22.22% | 16.29% | 31.18% | 717.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.40% | 3.75% | -2.47% | -1.31% | 16.06% |
| Operating Income | -4.05% | -28.36% | 34.87% | 36.35% | -34.40% |
| Income Before Tax | 24.40% | -24.80% | 68.10% | 5,588.74% | 146.31% |
| Income Tax Expenses | 87.79% | 20.11% | 35.99% | 331.34% | 278.36% |
| Earnings from Continuing Operations | -19.51% | -71.78% | 91.86% | 1,195.34% | 126.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.51% | -71.78% | 91.86% | 1,195.34% | 126.05% |
| EBIT | -4.05% | -28.36% | 34.87% | 36.35% | -34.40% |
| EBITDA | 43.59% | -4.98% | 26.31% | 34.08% | -33.55% |
| EPS Basic | -10.17% | -69.23% | 102.25% | 1,219.23% | 127.57% |
| Normalized Basic EPS | 0.58% | -34.52% | 77.72% | 62.91% | -35.96% |
| EPS Diluted | -10.17% | -68.00% | 102.25% | 1,219.23% | 127.57% |
| Normalized Diluted EPS | 0.77% | -32.93% | 81.48% | 62.91% | -36.21% |
| Average Basic Shares Outstanding | -10.85% | -8.66% | -5.22% | -2.78% | -5.37% |
| Average Diluted Shares Outstanding | -11.16% | -10.47% | -7.17% | -2.66% | -4.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |